Home » Prices » NASDAQ:ICPT

Intercept Pharmaceuticals, Inc. NASDAQ:ICPT

Today's live share price, quote history, chart & news

Price:
76.47 USD
Change:
-4.04 (-5.02%)
Key Stats
Price open 82.14
Previous close 80.51
Market cap 2.52B
Volume 1.45M
Day high 82.96
Day low 76.1
Year high 125
Year low 47.57
Year to date change -38.64%
P/E Ratio -7.13
Company Profile
Fundamentals
Insider Information
News

About Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.

Company information

Company name
Intercept Pharmaceuticals, Inc.
Exchange
Sector
Health Technology
Industry
Pharmaceuticals: Other
Employees
583
CEO
Mark E. Pruzanski
Address
10 Hudson Yards, New York, NY, 10001
Country
United States
Contact information
1.646.747.1000
Website
http://www.interceptpharma.com

Related companies

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.